← Leaderboards
Katsiaryna Bykov
Brigham And Women'S Hospital
$3,958,173
Attributed
$4,283,538
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,683,542 · 3
AHRQ$1,599,996 · 1
By mechanism
R01$3,174,516 · 2
K01$620,974 · 1
R21$488,048 · 1
Top collaborators
- Mengmeng Du1 shared
- Elizabeth David Kantor1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Seoyoung Catherine Kim$5,029,016
- Katherine N Cahill$6,985,885
- Zara R Cooper$5,346,007
- Reza Abdi$32,829,278
- Niteesh K Choudhry$10,267,534
Others in their field
Other Emerging Leaders on “Link”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Susan M Landau · University Of California Berkeley$47,252,026
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,507,271
- Kathleen Maletic Neuzil · Emory University$25,301,215
- Anthony Philippakis · University Of California Santa Cruz$23,897,237
- Bronwen Shaw · Medical College Of Wisconsin$18,756,649
Research focus
LinkPharmaceutical PreparationsPositioning AttributeDiabetes MellitusPatient CarePharmacoepidemiologyEvaluationInsurance ClaimsComorbidityElectronic Health RecordMethodologyObservational StudyPatient SubsetsSubgroupHeterogeneityResearch PersonnelEpidemiologyAgingInnovationBenefits And RisksDrug UsageDesignActive ComparatorDetection
Grant awards (12)
Evaluating the Impact of Non-COPD Medications on COPD Management$779,839
R01 · FY2025 · HL · contact PI
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy$97,200
K01 · FY2025 · AG · contact PI
Evaluating the Impact of Non-COPD Medications on COPD Management$794,681
R01 · FY2024 · HL · contact PI
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy$130,944
K01 · FY2024 · AG · contact PI
Drug interactions and opioid-related emergency room visits and hospitalizations among older adults$399,999
R01 · FY2023 · HS · contact PI
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy$130,942
K01 · FY2023 · AG · contact PI
Leveraging Medicare Linkages to Identify New Associations: Prescription Drugs and Digestive Cancer Risk$488,048
R21 · FY2022 · CA
Drug interactions and opioid-related emergency room visits and hospitalizations among older adults$399,999
R01 · FY2022 · HS · contact PI
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy$130,947
K01 · FY2022 · AG · contact PI
Drug interactions and opioid-related emergency room visits and hospitalizations among older adults$399,999
R01 · FY2021 · HS · contact PI
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy$130,941
K01 · FY2021 · AG · contact PI
Drug interactions and opioid-related emergency room visits and hospitalizations among older adults$399,999
R01 · FY2020 · HS · contact PI